December 4, 2025Discover OncologyOpen Access

Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia

View Full Paper

Ask AI

Bookmark

High bone marrow tumor burden correlates with shorter time to progression in asymptomatic Waldenström Macroglobulinemia.
Patients with greater disease burden had median time to progression of 64 months compared to 137 months for lower burden.
Observational analysis across asymptomatic Waldenström Macroglobulinemia patients identified clinical features with significant correlations to disease progression.
These findings emphasize the prognostic significance of monitoring disease burden to inform patient management strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Analysis reveals disease burden associated with shorter progression time in asymptomatic Waldenström Macroglobulinemia, suggesting clinical implications for monitoring.

Cite This Study

Danesin et al. (2025) studied this question.

synapsesocial.com/papers/6930dc9eea1aef094cca2e4e https://doi.org/10.1007/s12672-025-04142-2

View Full Paper

Ask AI

Bookmark

Implication

Analysis reveals disease burden associated with shorter progression time in asymptomatic Waldenström Macroglobulinemia, suggesting clinical implications for monitoring.

Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia

Key Points

Discussion

Implication

Cite This Study

Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider